Ignite Creation Date:
2025-12-25 @ 2:40 AM
Ignite Modification Date:
2026-03-04 @ 9:35 PM
Study NCT ID:
NCT05265234
Status:
UNKNOWN
Last Update Posted:
2022-03-03
First Post:
2021-12-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Dupilmuab for Atopic Dermatitis Monitored With Noninvasive Imaging.
Sponsor:
OptiSkin Medical
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
OPTI-003
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |